Maximize the insights gained from PDX Models
Our optimized PDX engraftment procedures and modern technologies, such as multi-omics, digital spatial analysis and biodistribution, boost the utilization of PDX models and provide comprehensive insights into their molecular landscape. To utilize the unique genomic features of PDX models obtained from patients of diversified cancer subtypes, stages and treatment backgrounds, we offer a broad range of ex vivo analysis capabilities . Additionally, we offer a variety of therapeutic approaches including adoptive cell therapies and combination therapies with radiation and radiopharmaceuticals to support your oncology research program. With our full suite of in vivo and ex vivo capabilities, you can maximize the insights gained from the unique features of PDX models.
Oncology experience you can count on
With more than 10.000 studies completed, we have amassed extensive experience and deep insights to inform end-to-end discovery oncology research. Unser Team unterstützt Sie dabei, die Effekte von Wirkstoffen und Biologics mithilfe menschlicher und syngener Tumormodellen zu bewerten und stellt Ihnen entscheidungsrelevante Daten zur Verfügung, um Ihren Wirkstoffkandidaten zum nächsten Durchbruch in der Krebsforschung zu machen. And if you are ready to move a lead candidate to IND/CTA and beyond, we have the unique ability to support you with testing throughout the entire development journey, anchored by a biomarker-driven strategy. With our experience, we help you gain efficiencies as we connect insights effectively from one stage to the next, empowering you to make more informed decisions every step of the way.